Genentech's COVID-19 Talk
A Talk by Craig Eagle (Vice President, Head of BioOncology, US Medical Affairs, Genentech)
About this Talk
Key Takeaways
- COVID has made telemedicine the norm and is changing how healthcare is delivered
- By relying on electronic processes, decentralized clinical trials offer opportunities for a more patient-centered approach
- At Genentech, we want to fully unlock the potential of telemedicine, generate data faster, expand access to clinical trials and improve outcomes for patients